Your English writing platform
Discover LudwigSuggestions(1)
Exact(9)
Direct and indirect costs were evaluated from payer, patient and societal perspectives.
We assessed the cost-effectiveness of adjuvant capecitabine from payer (UK National Health Service (NHS)) and societal perspectives.
Direct cost for physician visits including referrals to specialists, drugs and hospitalizations were considered from payer perspective and co-payments as well as transportation expenses from patient's perspective.
First, we did not interview all potential stakeholders, such as respiratory therapists, pharmacists, primary care physicians, surgeons, or representatives from payer groups and regulatory agencies.
Estimates for the number of deaths, hospitalizations and ED and outpatient visits were evaluated using three scenarios from payer and societal perspectives: 10%, 25%and50%0% fewer than the base case scenario.
This study's objective was to respond to growing interest from payer, policymaker, and clinical communities to compare the effectiveness of breast cancer assays that aim to provide health benefits and achieve overall cost savings.
Similar(51)
The wider commercial environment is seeing increasing pressure coming from payers to demonstrate clear benefits of therapies in order to justify high price tags.
There are increasing demands for improved outcomes from payers and the public.
The risk: Widespread adoption is dependent on reimbursement from payers like Medicare.
Shifts from fee-for-service (FFS) to value-based reimbursement (VBR) models continue to transfer a significant percentage of clinical and financial risk from payers to providers.
The patent cliff and increasing pricing pressure from payers urge for greater effectiveness and efficiency throughout the industry, including R&D.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com